Octagon Capital Advisors »

Aerovate Therapeutics shares owned by Octagon Capital Advisors

Quarter-by-quarter ownership of Aerovate Therapeutics (AVTE) shares owned by Octagon Capital Advisors from 13F filings

Historical chart of Octagon Capital Advisors investment in Aerovate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aerovate Therapeutics held by Octagon Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aerovate Therapeutics by Octagon Capital Advisors

Quarter filed Position value Share count Share price at filing
2024-06-30 $773k 465k 1.66
2024-03-31 $12M 404k 29.57
2023-12-31 $9.1M 404k 22.63
2023-09-30 $6.7M 497k 13.57
2023-06-30 $11M 622k 17.15
2023-03-31 $13M 622k 20.17
2022-12-31 $18M 622k 29.30